Medtronic (NYSE:MDT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $114.00 price target on the stock.
???????????????????? : ???????????(AI)???2035??111?2180???????????????????CAGR20.7%?????? [CNET News]
Medtronic (NYSE:MDT) is now covered by analysts at CICC Research. They set an "outperform" rating on the stock.
Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation